Shelton Capital Management Tandem Diabetes Care Inc Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$53.22 - $123.09 $177,754 - $411,120	-3,340 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$101.89 - $150.09 $697,742 - $1.03 Million	-6,848 Reduced 67.22%	3,340 $388,000
Q4 2021 Feb 11, 2022	BUY	$118.18 - $153.21 $353,121 - $457,791	2,988 Added 41.5%	10,188 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $74,808 - $103,520	-800 Reduced 10.0%	7,200 $860,000
Q2 2021 Aug 12, 2021	BUY	$77.0 - $100.19 $616,000 - $801,520	8,000 New	8,000 $779,000

359

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.76B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.